SPOTLIGHT -
Daratumumab as a Potential Treatment Option for Multiple Myeloma
Jacob Laubach, MD, MPP, from Dana-Farber Cancer Institute and an Instructor in Medicine at the Harvard Medical School, discusses daratumumab as a potential treatment option for patients with multiple myeloma.
